The scope of production covers various kinds of drug dosage forms and chemical bulk drugs, such as tablet, capsule, soft capsule, granule, dry-suspension, freeze-dried injection, small volume injection, large volume injection, API etc. The drugs have reached more than 200 finished products and 28 APIs & Intermediates, including Aobuke, Alfacalcidil soft capsule, Taizhiao, Ibuprofen soft capsule, Balsalazide Sodium capsule, Taierxin, Fructose Diphosphate Sodium Injection and so on, the main Chinese Patent Drugs include Ganmao Qingre soft capsule, Danshu soft capsule, Rupikang capsule, Yiqing soft capsule, Zhengxintai tablet, Qinpi Jiegu tablet, Gentongping capsule, Yisheng Bugu capsule, Suke Ganmao capsule, Oenothera Biennis Oil Soft Capsule and so on. Our products have been globally marketed with good reputation. Most of them are the first choice in the clinical application. In Dec. 2009, Dalian Tianyu Pharmaceutical Co., Ltd. and Dalian Aosen Pharmaceutical Co., Ltd. have been rewarded as ‘High-tech Enterprise’ by Dalian municipal government; and in Dec. 2010, Dalian Mingsen Pharmaceutical Co., Ltd. has been rewarded as ‘High-tech Enterprise’ by Dalianmunicipal government as well.

The medicine business subsidiary company is mainly focusing on Chinese Patent Drugs, which has set up a strategic cooperation with more than 100 well-known domestic manufacturers: build products, channel and brands together and reach common development. Until now, it has nearly 1000 kinds of products and covers major terminal sale channels almost all over the country.

Additionally, Dalian Mingsen Pharmaceutical Co., Ltd., which is the pharmaceutical subsidiary of chemical bulk drugs, has 6 production lines of chemical synthesis. The API products include Alginic Sodium Diester, Benproperine Phosphate, Balsalazide Sodium etc. Besides, this company also provides tech-service in synthesis of drug intermediates and bulk drugs. Currently, there are 6 intermediates to export after having passed the on-site inspection of Canada, Japan, Ireland and South Korea. Because of strong technical support, standard managements and professional team with rich experiences in both management and marketing, the company has laid a solid foundation for the future development.

Dalian Aosen Pharmaceutical Corporation Ltd. focus on strengthening core competitiveness, by making the natural drug & API as the main technical field, R & D as development power, marketing as a growth breakthrough and capital operation as accelerator, in order to ensure to be a Listed Company in next year.

Dalian Aosen Pharmaceutical Corporation Ltd. business philosophy is always ‘Quality First, Credit upmost’. Many foreign customers are our good strategic partners, and we also have good relationship with government. We sincerely hope to build great cooperation with various kinds of companies in the world. With technical innovation, we will continue to provide safe and effective drugs for society, to bring a greater income for investments, and to create maximum benefits for partners.